-
Samsung Galaxy Buds Active Leak Reveals ANC, Ear-Hook Design and One UI 9.5 Integration
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
Making the Most of a Long Weekend Without Leaving Town
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
Paul Scribner on General Holdings Limited's Role as a Principal Investor in Complex, Cross-Border Opportunities
-
Best Gold IRA Rollover Companies 2026 Announced: How to Choose and Gold IRA Rollover Basics Explained in New Guide
-
Remergify and Ready Set Fund Grow Launch Municipal Opportunity Zone Framework to Modernize Core Public Utilities and Bridge the Divide Between Luxury Growth and Community Stability
-
CreditRiskMonitor Trade Contributors Use New Self-Serve Feature
-
Caldwell Expands Leadership Advisory With Launch of Caldwell Leadership Intelligence
-
neoseek Builds on a Decade of Engineering Expertise to Accelerate Global Expansion in Portable Charging
-
Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4
-
Route1 Announces Issuance of Shares for Compensation
-
Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System
-
After 20 Years of Modernizing Other Companies' Software, Polcode Turns the Lens on Itself
-
Celtic Bank Selects Infinant to Scale Its Embedded Finance Programs
-
BlackBerry and Hazard Management Cayman Islands Renew Critical Alerting System for Emergencies and Public Safety
-
Long Island Capital Alliance to Host Technology Capital Forum
-
Philadelphia Sexual Assault Lawyer David P. Thiruselvam Explains Who Can Be Named in a Civil Sexual Assault Claim
Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4
270% Net Income Jump, $300K+ Q4 Private Sales, and $250,000 Software Agreement Underpin Decision to Suspend Equity Issuance Through 2027
MESA, AZ / ACCESS Newswire / November 19, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it has paused dilution and does not currently plan to resume equity issuance until 2027 when expansion plans and funding are to be re-evaluated in efforts to align with shareholder value and continuing near term revenue. The decision follows the Company's third-quarter results showing a sharp improvement in profitability and accelerating private sales activity at its Infinite Auctions subsidiary.
On November 12, MDCE reported unaudited results for the three and nine months ended September 30, 2026. Third-quarter sales revenue rose 13% to $538,981. Gross profit increased 55% to $240,839. Net operating income rose 254% to $192,565, and net income increased 270% to $192,565. For the nine-month period, the Company reported net income of $198,883 compared to a net loss of $145,347 in the prior-year period. Gross profit rose to $332,744. The Company ended the quarter with zero current liabilities and cash of $102,172.
Supporting the decision to pause dilution is revenue generation at Infinite Auctions. Private sales at the subsidiary have already surpassed $300,000 in the fourth quarter. This activity builds on the subsidiary's partnership with a multi-billion-dollar sports card and collectibles company, under which six-figure transaction activity has already occurred. Real Game Used continues to maintain a continuous backlog of customer and auction-brand authentication work through its automated submission system. The Company has also announced that its subsidiaries are managing approximately $20 million in private collectibles assets, with potential net profits contingent on completed sales.
In parallel, technical development continues under MDCE's first paid external software agreement, valued at up to $250,000, covering an integrated web and enterprise platform for inventory and sales workflows. The first payment under that agreement has been initiated. StrainScan Pro enterprise demonstrations remain active. Internal evaluation continues on MDCE Melanoma Scan Beta and the wound-monitoring application, with updated technical results available on the Company's corporate website.
"Shareholders have expressed concern about dilution and this is our response," said Marshall Perkins, CEO of Medical Care Technologies. "The third-quarter results showed net income up 270% and a clear improvement in profitability. Infinite Auctions private sales have already surpassed $300,000 in Q4. That revenue, together with the software agreement now in active development and the ongoing work at our subsidiaries, gives us the ability to pause further equity issuance through 2027. The focus is on building from the commercial activity we already have in motion."
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company owns subsidiaries Infinite Auctions and Real Game Used. Visit: medicalcaretechnologies.com | infiniteauctions.com | realgameused.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about the Company's business and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Such risks include the Company's ability to continue generating revenue from subsidiaries and software activities, complete development under existing agreements, sustain private sales activity, and manage its capital structure. Any decision to pause or resume equity issuance is subject to change based on operating results, capital needs, and other factors. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Website: medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
D.Kaufman--AMWN